Facts
The International Rugby Board (IRB) alleges Martin Nuñez Lasalle (the player) for a violation of the Anti-Doping Rules. On 4 December 2010, while playing for the Argentina team in the World Sevens Series Tournament in Dubai, the Player underwent in-competition drug testing. The sample of the urine specimen which the Player provided was positive for the prohibited substance, 19-Norandrosterone a metabolite of nandrolone at a concentration of 14 ng/ml.
History
The player suffered from a shoulder injury, for the treatment he used a number of drugs – dexametasone, meprednisone, deca-durobolin and amitriptiline. Deca-Durabolin labels and containers clearly refer to Nandrolone.
Decision
On 4 December 2010, the Player committed an anti-doping rule violation. The sanction imposed for this anti-doping rule violation is a period of Ineligibility of 15 months, commencing on 23 December 2010 (the date upon which the Player was notified of the adverse analytical finding and provisionally suspended) and concluding (but inclusive of) 22 March 2012.
